Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex
- PMID: 7517207
Antibodies in sulfonamide-induced immune thrombocytopenia recognize calcium-dependent epitopes on the glycoprotein IIb/IIIa complex
Abstract
Drug-dependent IgG antibodies (DDAb) induced by sulfamethoxazole (SMX) and sulfisoxazole (SIX) were identified by flow cytometry in 15 patients who developed thrombocytopenia while taking one of these medications. Fourteen of the 15 DDAb were specific solely for the glycoprotein (GP)IIb/IIIa complex, and 13 of these reacted wholly or in part with epitopes present only on the intact GPIIb/IIIa heterodimer. None of 12 SMX-induced DDAb cross-reacted with SIX, but one of three SIX-induced antibodies reacted with SMX. Each of 10 SMX-induced DDAb tested reacted with the N1-acetyl metabolite of SMX, but only one reacted fully with the N4-acetyl derivative. Detection of the SMX- and SIX-dependent antibodies was facilitated by using bovine serum albumin (BSA) to achieve suspension of these weakly soluble drugs in an aqueous medium. Our findings indicate that DDAb induced by SMX and SIX, in contrast to those induced by quinidine and quinine, are mainly specific for GPIIb/IIIa and react preferentially with calcium-dependent epitopes present only on the intact GPIIb/IIIa heterodimer.
Similar articles
-
Characteristics of quinine- and quinidine-induced antibodies specific for platelet glycoproteins IIb and IIIa.Blood. 1991 Jun 15;77(12):2668-76. Blood. 1991. PMID: 1710517
-
Characterization of the binding domains on platelet glycoproteins Ib-IX and IIb/IIIa complexes for the quinine/quinidine-dependent antibodies.Blood. 1991 May 15;77(10):2190-9. Blood. 1991. PMID: 1709374
-
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated.Blood. 2002 May 15;99(10):3540-6. doi: 10.1182/blood.v99.10.3540. Blood. 2002. PMID: 11986205
-
Glycoprotein IIb/IIIa antagonists: potential induction and detection of drug-dependent antiplatelet antibodies.Am Heart J. 1998 May;135(5 Pt 2 Su):S152-9. doi: 10.1016/s0002-8703(98)70243-1. Am Heart J. 1998. PMID: 9588394 Review.
-
Drug-induced immune thrombocytopenia: incidence, clinical features, laboratory testing, and pathogenic mechanisms.Immunohematology. 2014;30(2):55-65. Immunohematology. 2014. PMID: 25247620 Review.
Cited by
-
Safety Assessment of an Oral Therapeutic Dose of Firocoxib on Healthy Horses.Vet Sci. 2023 Aug 22;10(9):531. doi: 10.3390/vetsci10090531. Vet Sci. 2023. PMID: 37756053 Free PMC article.
-
Sulfonamide Hypersensitivity.Clin Rev Allergy Immunol. 2022 Jun;62(3):400-412. doi: 10.1007/s12016-021-08872-3. Epub 2021 Jul 1. Clin Rev Allergy Immunol. 2022. PMID: 34212341 Review.
-
Life-Threatening Intrapulmonary Hemorrhage due to Vancomycin-Induced Thrombocytopenia: A Case Report.Case Rep Crit Care. 2020 Sep 30;2020:8890335. doi: 10.1155/2020/8890335. eCollection 2020. Case Rep Crit Care. 2020. PMID: 33062342 Free PMC article.
-
Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia.J Clin Med. 2020 Jul 13;9(7):2212. doi: 10.3390/jcm9072212. J Clin Med. 2020. PMID: 32668640 Free PMC article. Review.
-
Sulfonamide Drug Allergy.Curr Allergy Asthma Rep. 2018 Jun 6;18(7):38. doi: 10.1007/s11882-018-0791-9. Curr Allergy Asthma Rep. 2018. PMID: 29876667 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
